Dialogue Health Technologies Inc.
DLHTF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $185 | $225 | $263 | $268 |
| - Cash | $63 | $104 | $42 | $25 |
| + Debt | $2 | $3 | $3 | $4 |
| Enterprise Value | $125 | $124 | $224 | $247 |
| Revenue | $87 | $68 | $36 | $10 |
| % Growth | 28% | 90.1% | 254.9% | – |
| Gross Profit | $43 | $29 | $14 | $5 |
| % Margin | 49.7% | 42.3% | 40.2% | 54.4% |
| EBITDA | -$21 | -$249 | -$17 | -$11 |
| % Margin | -24.5% | -366.2% | -48.4% | -108.3% |
| Net Income | -$26 | -$251 | -$20 | -$12 |
| % Margin | -29.8% | -369.4% | -56.5% | -119.4% |
| EPS Diluted | -0.39 | -4.48 | -0.31 | -0.19 |
| % Growth | 91.3% | -1,345.2% | -63.2% | – |
| Operating Cash Flow | -$16 | -$23 | -$18 | -$13 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$16 | -$24 | -$19 | -$14 |